| Literature DB >> 25420756 |
Francine Chevalier, Carolina Fernandez-Lao, Antonio Ignacio Cuesta-Vargas.
Abstract
BACKGROUND: To describe the clinical, functional and quality of life characteristics in women with Stress Urinary Incontinence (SUI). In addition, to analyse the relationship between the variables reported by the patients and those informed by the clinicians, and the relationship between instrumented variables and the manual pelvic floor strength assessment.Entities:
Mesh:
Year: 2014 PMID: 25420756 PMCID: PMC4251926 DOI: 10.1186/s12905-014-0143-4
Source DB: PubMed Journal: BMC Womens Health ISSN: 1472-6874 Impact factor: 2.809
Sociodemographic anthropometric and quality of life characteristics
|
|
|
|---|---|
|
| 39.93 ± 12.27 |
|
| 70.75 ± 25.94 |
|
| 164.48 ± 7.41 |
|
| 24.49 ± 3.54 |
|
| 69.32 ± 17.23 |
|
| 0.85 ± 0.18 |
|
| 47.54 ± 10.14 |
|
| 48.90 ± 9.73 |
|
| 50.10 ± 10.54 |
|
| 38.92 ± 12.15 |
|
| 49.89 ± 9.62 |
|
| 50.17 ± 6.72 |
|
| 47.74 ± 10.44 |
|
| 51.70 ± 8.10 |
|
| 38.06 ± 14. 49 |
|
| 40.02 ± 12.14 |
Values expressed as mean ± Standard Deviation.
SF-12 PCS. Physical Component Summary.
SF-12 MCS. Mental Component Summary.
Items’ 1–11 IU questionnaire (deliveries information)
|
| |||
|---|---|---|---|
|
| 1.89 ± 1.21 | ||
|
| 1.56 ± 0.84 | ||
|
|
|
|
|
| 3327.43 ± 1.19 | 3422.72 ± 533.12 | 3468.04 ± 58.14 | |
|
|
|
|
|
| 125 (64.4%) | 34 (17.5%) | 35 (18%) | |
|
|
|
|
|
| 65 (78.3%) | 10 (12.0%) | 8 (9.6%) | |
|
|
|
|
|
| 22 (81.5%) | 5 (18.5%) | 0 (0%) | |
|
|
|
| |
| 5 (2.45%) | 201 (97.55%) | ||
|
|
|
| |
| 149 (73%) | 54 (26.6%) | ||
Values expressed as mean ± Standard Deviation (95% Confidence Interval) and absolute percentages.
Items 12–23 UI questionnaire (Urinary and fecal incontinence)
|
| |||
|---|---|---|---|
|
| 7.40 ± 2.45 | ||
|
| 0.80 ± 1.17 | ||
|
|
|
|
|
| 20 (9.3%) | 44 (20.3%) | 152 (70.4%) | |
|
|
|
| |
| 69 (31.8%) | 148 (68.2%) | ||
|
|
|
| |
| 89 (41.4%) | 126 (58.6%) | ||
|
|
|
| |
| 100 (46.3%) | 116 (53.7%) | ||
|
| |||
|
|
|
| |
| 147 (68.1%) | 69 (31.9%) | ||
|
|
|
| |
| 121 (56.3%) | 94 (43.7%) | ||
|
|
|
| |
| 95 (44.6%) | 118 (55.4%) | ||
|
|
|
| |
| 106 (49.1%) | 110 (50.9%) | ||
|
|
|
| |
| 88 (40.7%) | 128 (59.3%) | ||
|
| 2.38 ± 1.147 | ||
|
|
|
| |
| 118 (54.4%) | 99 (45.6) | ||
|
|
|
| |
| 66 (30.4%) | 150 (69.1%) | ||
|
|
|
| |
| 88 (40.6%) | 129 (40.4%) | ||
Values expressed as mean ± Standard Deviation (95% Confidence Interval) and absolute percentages.
Items 23–38 UI questionnaire (heterogeneous)
|
| ||||||||
|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
| 31 (14.4%) | 48 (22.2%) | 1 (0.5%) | 31 (14.4%) | 53 (24.5%) | 40 (18.5%) | 2 (0.9%) | 10 (4.6%) | |
|
|
|
| ||||||
| 122 (50.6%) | 94 (43.5%) | |||||||
|
|
|
| ||||||
| 137 (63.4%) | 79 (33.6%) | |||||||
|
|
|
| ||||||
| 185 (87.3%) | 27 (12.7%) | |||||||
|
|
|
|
|
| ||||
| 96 (57.2%) | 74 (40.7%) | 4 (1.8%) | 8 (3.7%) | |||||
|
|
|
| ||||||
| 113 (52.3%) | 103 (47.7%) | |||||||
|
|
|
| ||||||
| 147 (68.1%) | 69 (31.9%) | |||||||
|
|
| |||||||
|
| 55 (25.3%) | 162 (74.7%) | ||||||
|
| ||||||||
|
|
|
| ||||||
| 117 (55.7%) | 93 (44.3%) | |||||||
|
|
|
| ||||||
| 78 (37.3%) | 131 (62.7%) | |||||||
|
|
|
| ||||||
| 128 (59.5%) | 87 (40.5%) | |||||||
|
|
|
|
|
|
|
|
| |
| 14 (6.5%) | 15 (6.9%) | 0 (0%) | 30 (13.9%) | 105 (48.6%) | 30 (13.9%) | 21 (9.7%) | ||
|
|
|
|
|
|
|
|
| |
| 5 (2.3%) | 9 (4.1%) | 10 (4.6%) | 1 (0.5%) | 134 (61.8%) | 43 (19.8%) | 15 (6.9%) | ||
|
|
|
| ||||||
| 79 (37.3%) | 133 (62.7%) | |||||||
|
|
|
| ||||||
| 19 (23.2%) | 63 (76.8%) | |||||||
|
| 47.23 ± 8.05 | |||||||
|
|
|
| ||||||
| 81 (37.3%) | 111 (51.2%) 25 (11.5%) | |||||||
Values expressed as mean ± Standard Deviation (95% Confidence Interval) and absolute percentages.
Correlation between outcomes informed by the clinician (n = 208)
|
|
|
|
| ||
|---|---|---|---|---|---|
|
| Pearson correlation | 1 | 0,844** | 0,855** | 0,021 |
|
| 0,000 | 0,000 | 0,807 | ||
|
| Pearson correlation | 0,844** | 1 | 0,952** | −0,066 |
|
| 0,000 | 0,000 | 0,348 | ||
|
| Pearson correlation | 0,855** | 0,952** | 1 | −0,139* |
|
| 0,000 | 0,000 | 0,047 | ||
|
| Pearson correlation | 0,021 | −0,066 | −0,139* | 1 |
|
| 0,807 | 0,348 | 0,047 |
**Significative correlation p ≤ 0,001.
*Significative correlation p ≤ 0,05.
Correlations between outcomes reported by the patients and outcomes informed by the clinician
|
|
|
|
|
|
|
|
| ||
|---|---|---|---|---|---|---|---|---|---|
|
| Pearson Correlation | 1 | -,064 | -,066 | -,132 | ,076 | -,396* | -,142 | -,023 |
|
| ,719 | ,675 | ,400 | ,654 | ,015 | ,371 | ,886 | ||
|
| Pearson Correlation | -,064 | 1 | ,821** | ,838** | ,118 | ,112 | -,168 | ,114 |
|
| ,719 | ,000 | ,000 | ,541 | ,562 | ,350 | ,528 | ||
|
| Pearson Correlation | -,066 | ,821** | 1 | ,983** | ,009 | ,063 | -,172 | ,194 |
|
| ,675 | ,000 | ,000 | ,956 | ,712 | ,282 | ,224 | ||
|
| Pearson Correlation | -,132 | ,838** | ,983** | 1 | ,010 | ,110 | -,197 | ,198 |
|
| ,400 | ,000 | ,000 | ,955 | ,516 | ,217 | ,214 | ||
|
| Pearson Correlation | ,076 | ,118 | ,009 | ,010 | 1 | -,223 | ,494** | ,298 |
|
| ,654 | ,541 | ,956 | ,955 | ,178 | ,002 | ,077 | ||
|
| Pearson Correlation | -,396* | ,112 | ,063 | ,110 | -,223 | 1 | ,239 | ,310 |
|
| ,015 | ,562 | ,712 | ,516 | ,178 | ,161 | ,066 | ||
|
| Pearson Correlation | -,142 | -,168 | -,172 | -,197 | ,494** | ,239 | 1 | ,275 |
|
| ,371 | ,350 | ,282 | ,217 | ,002 | ,161 | ,074 | ||
|
| Pearson Correlation | -,023 | ,114 | ,194 | ,198 | ,298 | ,310 | ,275 | 1 |
|
| ,886 | ,528 | ,224 | ,214 | ,077 | ,066 | ,074 | ||
**Significative correlation p ≤ 0,001.
*Significative correlation p ≤ 0,05.
SF-12 PCS. Physical Component Summary.
SF-12 MCS. Mental Component Summary.